We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$41.7M
AUM Growth
-$122K
(-0.29%)
Cap. Flow
-$658K
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
60.79%
Holding
55
New
5
Increased
3
Reduced
14
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARAA
Paramount Global Class A
PARAA
|
+$764K |
| 2 |
CRZO
Carrizo Oil & Gas Inc
CRZO
|
+$694K |
| 3 |
MiMedx Group
MDXG
|
+$351K |
| 4 |
SRCI
SRC Energy Inc
SRCI
|
+$272K |
| 5 |
NTRP
Neurotrope, Inc. Common
NTRP
|
+$198K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$982K |
| 2 |
Helen of Troy
HELE
|
+$638K |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$599K |
| 4 |
RTEC
Rudolph Technologies Inc
RTEC
|
+$466K |
| 5 |
Tower Semiconductor
TSEM
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Healthcare | 17.14% |
| 3 | Materials | 11.02% |
| 4 | Energy | 10.6% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRS
1
DELISTED
Amyris Inc.
AMRS
| $4.58M | 10.99% |
717,555
| – | – |
|
2
Apple
AAPL
$4.78T
| $3.64M | 8.72% |
78,636
| – | – |
|
3
NexGen Energy
NXE
$6.1B
| $3.29M | 7.89% |
1,769,465
| – | – |
|
|
4
Tower Semiconductor
TSEM
$28.6B
| $2.57M | 6.15% |
116,570
-7,945
| -6% | -$202K |
|
5
Qualcomm
QCOM
$179B
| $2.17M | 5.21% |
38,744
-1,865
| -5% | -$104K |
|
|
PARAA
6
DELISTED
Paramount Global Class A
PARAA
| $2M | 4.79% |
35,518
+14,550
| +69% | +$764K |
|
|
NTRP
7
DELISTED
Neurotrope, Inc. Common
NTRP
| $1.92M | 4.6% |
198,195
+21,455
| +12% | +$198K |
|
|
RTEC
8
DELISTED
Rudolph Technologies Inc
RTEC
| $1.58M | 3.8% |
53,558
-15,333
| -22% | -$466K |
|
|
9
Ionis Pharmaceuticals
IONS
$9.36B
| $1.53M | 3.67% |
36,735
-13,515
| -27% | -$599K |
|
10
Aflac
AFL
$63.5B
| $1.48M | 3.56% |
34,480
| – | – |
|
|
11
Corcept Therapeutics
CORT
$10.3B
| $1.39M | 3.32% |
88,154
-56,448
| -39% | -$982K |
|
12
Onto Innovation
ONTO
$14.2B
| $1.05M | 2.52% |
29,664
-610
| -2% | -$20.9K |
|
13
Alaska Air
ALK
$5.05B
| $1.01M | 2.42% |
16,739
-415
| -2% | -$25.7K |
|
14
Ichor Holdings
ICHR
$3.17B
| $920K | 2.21% |
43,340
-855
| -2% | -$20.4K |
|
15
Honeywell
HON
$77.8B
| $914K | 2.19% |
7,023
| – | – |
|
|
CRZO
16
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $838K | 2.01% |
+30,105
| New | +$694K |
|
|
CPRX
17
DELISTED
Catalyst Pharmaceutical
CPRX
| $782K | 1.87% |
250,683
-5,910
| -2% | -$17.9K |
|
18
Tesla
TSLA
$1.26T
| $741K | 1.78% |
32,415
-300
| -0.9% | -$6.1K |
|
19
JetBlue
JBLU
$1.87B
| $722K | 1.73% |
38,044
-1,080
| -3% | -$20.8K |
|
20
BeyondSpring
BYSI
$45.2M
| $636K | 1.52% |
23,978
+230
| +1% | +$6.39K |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $563K | 1.35% |
7,086
-66
| -0.9% | -$5.48K |
|
|
SF
22
Stifel
SF
$12B
| $554K | 1.33% |
23,861
| – | – |
|
23
Philip Morris
PM
$300B
| $466K | 1.12% |
5,772
| – | – |
|
24
Netflix
NFLX
$286B
| $425K | 1.02% |
10,850
| – | – |
|
25
PepsiCo
PEP
$184B
| $408K | 0.98% |
3,750
| – | – |
|
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Tanaka Capital Management held 55 positions worth $41.7M, down 0.29% from $41.8M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Tanaka Capital Management's Q2 2018 filing shows 5 new, 3 increased, 14 reduced and 1 closed positions. Its largest new stake was Carrizo Oil & Gas Inc: 30,105 shares worth $838K. The largest sale was Corcept Therapeutics, an estimated $982K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Materials.
- Tanaka Capital Management's largest Q2 2018 buy was Carrizo Oil & Gas Inc: 30,105 shares worth $838K.
- Tanaka Capital Management added most to Paramount Global Class A in Q2 2018, an estimated $764K increase.
- Tanaka Capital Management's biggest Q2 2018 reduction was Corcept Therapeutics, cutting an estimated $982K.
- Tanaka Capital Management fully exited Helen of Troy in Q2 2018, selling an estimated $638K.
- Tanaka Capital Management's ten largest holdings make up 61% of its $41.7M portfolio in Q2 2018.
- Tanaka Capital Management opened 5 new positions and closed 1 in Q2 2018.
- Tanaka Capital Management's portfolio value fell 0.29% quarter-over-quarter to $41.7M.
Based on Tanaka Capital Management's 13F filing for Q2 2018, filed 16 Aug 2018.